Katja Betts und Aav Person-Info 

( Ich bin Katja Betts)
(1 - 8 von 8
)

AAV Gene Therapy: Monitoring Manufacturing

european-biotechnology.com
— by Katja Betts, CEO, Progen. Adeno-associated viruses (AAV) have revolutionised gene therapies as safe and effective gene shuttles. › ...

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 ...

d1io3yog0oux5.cloudfront.net
— experience," said Katja Betts, CEO of PROGEN. "As the leader in AAV capsid titer quantification and exclusive manufacturer of the most ... › news ›

Bio-Techne launches simple Plex Adeno-associated virus ...

www.pharmabiz.com
— “Working with ProteinSimple to develop the Simple Plex AAV2 assay was a great experience,” said Katja Betts, CEO of PROGEN. › News...
+1